Vanda Pharmaceuticals Inc.
TREATMENT OF CIRCADIAN RHYTHM DISORDERS

Last updated:

Abstract:

Embodiments of the invention relate to the use of a melatonin agonist in the treatment of free running circadian rhythms in patients, including light perception impaired patients, e.g., blind patients, and to methods of measuring circadian rhythm.

Status:
Application
Type:

Utility

Filling date:

15 Feb 2022

Issue date:

2 Jun 2022